Search

Your search keyword '"Fekkar, Arnaud"' showing total 207 results

Search Constraints

Start Over You searched for: Author "Fekkar, Arnaud" Remove constraint Author: "Fekkar, Arnaud"
207 results on '"Fekkar, Arnaud"'

Search Results

1. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

2. Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based study

3. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020)

4. Sexually Transmitted Trichophyton mentagrophytes Genotype VII Infection among Men Who Have Sex with Men

5. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia

7. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

10. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

11. Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with Acalabrutinib—findings from three cases

12. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020)

14. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety

15. Cladophialophora Bantiana  Phaeohyphomycosis in France: A Reappraisal of Epidemiology, Therapeutic Strategy, and Outcome

16. Gradient concentration strip–specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes

17. Invasive Infections with Nannizziopsis obscura Species Complex in 9 Patients from West Africa, France, 2004-2020

18. Longitudinally extensive posterolateral myelitis revealing invasive CNS aspergillosis in an immunocompetent patient.

19. Cryptococcus neoformans Infections Differ Among Human Immunodeficiency Virus (HIV)–Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in France.

20. Improving the Detection of Epidemic Clones in Candida parapsilosis Outbreaks by Combining MALDI-TOF Mass Spectrometry and Deep Learning Approaches

22. Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia.

24. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial

26. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

28. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

29. Occurrence of Candidemia in Patients with COVID-19 Admitted to Five ICUs in France

30. Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France

31. Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation

32. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

33. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient

34. Identification of molds with MALDI-TOF mass spectrometry: performance of the newly developed MSI-2 application in comparison with the Bruker filamentous fungi database and MSI-1

37. Antifungal Susceptibility of 182 Fusarium Species Isolates from 20 European Centers: Comparison between EUCAST and Gradient Concentration Strip Methods

38. Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease

39. Identification of Molds with Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: Performance of the Newly Developed MSI-2 Application in Comparison with the Bruker Filamentous Fungi Database and MSI-1

41. Performance of Repeated Measures of (1–3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial

42. Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study

43. Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths

45. Clinical Origin and Species Distribution of Fusarium spp. Isolates Identified by Molecular Sequencing and Mass Spectrometry: A European Multicenter Hospital Prospective Study

46. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases

48. High Prevalence of Fungal Infections in Mechanically Ventilated COVID-19 Patients in the ICU: The French Multicenter MYCOVID Study

50. The impact of lowering the cut-off value on the sensitivity of the Platelia Elisa IgG (Bio-Rad) test for toxoplasmosis diagnosis

Catalog

Books, media, physical & digital resources